HIV News and Research

RSS

Enzyme treatment may prevent or reduce liver damage caused by excess alcohol consumption

An intestinal enzyme previously shown to keep bacterial toxins from passing from the gastrointestinal system into the bloodstream may be able to prevent or reduce the liver damage caused by excess alcohol consumption.

25 Apr 2017

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T cells to the tumors.

25 Apr 2017

Virginia Mason earns straight A's in new Leapfrog Hospital Safety Grade program

The Leapfrog Group, a leading national nonprofit watchdog on hospital quality and safety, recently announced that Virginia Mason has once again received an "A" for patient safety in the new Leapfrog Hospital Safety Grades.

21 Apr 2017

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Monoclonal antibody-based therapies have revolutionized treatments of cancer and autoimmune diseases because of their specificity and limited toxicity.

21 Apr 2017

Alcoholism may have different effects on the brain’s reward system of women than in men

A collaborative study between researchers at Massachusetts General Hospital and Boston University School of Medicine has found evidence implying that alcoholism may have different effects on the reward system in the brains of women than it does in men.

21 Apr 2017

Study: Improving health and wellbeing of adolescents could bring 10-fold economic benefit

As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs

21 Apr 2017

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

The World Health Organization (WHO) has published the first-ever Global Hepatitis Report. The World Hepatitis Alliance (WHA) welcomes the publication, which is a follow-up to WHO’s Global Strategy on Viral Hepatitis, and has set the goal to eliminate viral hepatitis as a public health threat by 2030.

21 Apr 2017

New model may provide vital insights into life-saving treatment for CMV infection

At-risk patients, such as those with HIV or transplant recipients, could benefit from potentially life-saving study carried out by a University of Surrey led group of international researchers.

21 Apr 2017

New behavioral intervention program could help reduce HIV infection rates among Latino men

Men who have sex with men accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.

20 Apr 2017

MGH researchers provide direct link between ‘leaky gut’ and chronic inflammatory disease

With the help of genetically engineered mice, scientists at the Massachusetts General Hospital are moving closer to establishing the role that increased intestinal permeability, sometimes called a "leaky gut," plays in chronic inflammatory conditions.

20 Apr 2017

Researchers report new evidence that defective HIV proviruses distract immune system

Researchers at Johns Hopkins and George Washington universities report new evidence that proteins created by defective forms of HIV long previously believed to be harmless actually interact with our immune systems and are actively monitored by a specific type of immune cell, called cytotoxic T cells.

19 Apr 2017

New study reports long-term infectious disease trends in China after SARS outbreak

Following the severe acute respiratory syndrome (SARS) outbreak in 2003, China stepped up its prevention and control methods for all infectious diseases, and rates of infection have levelled off since 2009.

19 Apr 2017

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

The HIV Prevention Trials Network, which includes McGovern Medical School at The University of Texas Health Science Center at Houston, has launched a study to evaluate whether a new injectable medication can work as well as an existing oral pill to safely protect against HIV among men who have sex with men (MSM) and transgender women (TGW) who have sex with men.

18 Apr 2017

Positive emotion intervention improves health in people newly diagnosed with HIV

When individuals recently diagnosed with HIV were coached to practice skills to help them experience positive emotions, the result was less HIV in their blood and lower antidepressant use, reports a new Northwestern Medicine study.

17 Apr 2017

Nanoparticle-programmed immune cells can slow progression of leukemia in mouse model

Researchers at Fred Hutchinson Cancer Research Center have developed biodegradable nanoparticles that can be used to genetically program immune cells to recognize and destroy cancer cells -- while the immune cells are still inside the body.

17 Apr 2017

Discovery of additional viral reservoir reveals new target for HIV cure research

HIV cure research to date has focused on clearing the virus from T cells, a type of white blood cell that is an essential part of the immune system.

17 Apr 2017

Injection drug use linked to increase in immune activation, says researcher

The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system.

13 Apr 2017

International research effort reveals major insights into spread of West African Ebola epidemic

An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.

12 Apr 2017

NIH scientists identify protein complexes involved in promoting HSV infection and reactivation

Herpes simplex virus (HSV) infections last a lifetime. Once a person has been infected, the virus can remain dormant (latent) for years before periodically reactivating to cause recurrent disease. This poorly understood cycle has frustrated scientists for years.

12 Apr 2017

TSRI scientists find new way to make cell population resistant to HIV

Scientists at The Scripps Research Institute have found a way to tether HIV-fighting antibodies to immune cells, creating a cell population resistant to the virus.

11 Apr 2017

HIV News and Research

Enzyme treatment may prevent or reduce liver damage caused by excess alcohol consumption

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

Virginia Mason earns straight A's in new Leapfrog Hospital Safety Grade program

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Alcoholism may have different effects on the brain’s reward system of women than in men

Study: Improving health and wellbeing of adolescents could bring 10-fold economic benefit

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

New model may provide vital insights into life-saving treatment for CMV infection

New behavioral intervention program could help reduce HIV infection rates among Latino men

MGH researchers provide direct link between ‘leaky gut’ and chronic inflammatory disease

Researchers report new evidence that defective HIV proviruses distract immune system

New study reports long-term infectious disease trends in China after SARS outbreak

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

Positive emotion intervention improves health in people newly diagnosed with HIV

Nanoparticle-programmed immune cells can slow progression of leukemia in mouse model

Discovery of additional viral reservoir reveals new target for HIV cure research

Injection drug use linked to increase in immune activation, says researcher

International research effort reveals major insights into spread of West African Ebola epidemic

NIH scientists identify protein complexes involved in promoting HSV infection and reactivation

TSRI scientists find new way to make cell population resistant to HIV

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News